Transepidermal water loss during conventional phototherapy in nonhemolytic hyperbilirubinemia term infants

S Wananukul1, P Praisuwanna

  • 1Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

The evaporation rate from the skin was measured in 40 healthy term infants and 40 non-hemolytic jaundice term infants who required phototherapy. All infants were born at the gestational age of 38-41 weeks. The method for measurement of evaporation rate was based on determination of the water pressure gradient close to the skin surface. Conventional phototherapy was given in open cribs. In the phototherapy group, non of the infants had received phototherapy before the start of measurement. Evaporation rate was measured at the chest, interscapular and buttock. The measurement was made before phototherapy, 30 minutes, and 6 hours after starting phototherapy. The mean evaporation rate increased from 7.2 to 7.8 and 8.4 g/m2 h, respectively (p<0.001). In the control group, the measurement was made at the consecutive time as in the phototherapy group. The mean of the evaporate rate was 7.3, 7.6 and 7.5 g/m2 h (p=0.30). We conclude that conventional phototherapy in full term infants in open cribs increases transepidermal water loss.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...